Fungal infection

Not yet recruiting

• Conditions: Local infection of the skin and subcutaneous tissue, unspecified. Ayurveda Condition: DADRU-KUSHTHAH,

• Registration Number: CTRI/2021/05/033562
• Lead Sponsor: Gurukul Campus UAU Haridwar

Brief Summary

This study is a open label, single arm clinical trial to determine the Efficacy of Laghu Manjishtadi Kwath and Adagazadi lepa in Dadru for age group between 18-60 years daily for 30 days . The study will be conducted at UAU, Gurukul Campus, Haridwar in 40 patients. The assessment will be done on the basis of Subjective and Objective parameters. The study will be conducted at OPD/IPD level of P.G. Department of Kaya Chikitsa. The assessment will be done at 1st,10th day, 20th day, 30th day of the clinical trial and the results obtained will be tabulated and statistically analyzed using appropriate tests.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-05-18
• Last Update Posted: 2021-11-05

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Patients having classical features of dadru.
• Both previously treated and fresh cases will be taken.
• Chronicity upto 5 years.
• Patients of either sex.
• Patients from age group 18-60 years.

Exclusion Criteria

• Patient suffering from Dibetes Mellitus.
• Pregnant and lactating women.
• Chronicity more than 5 years.
• Patients of age below 18 and more than 60 years.
• Patients of Dadru with any chronic systemic disorder which interferes with the present study.
• Patients with serious medical illness and psychiatric disorder will be excluded.
• Drug induced reaction.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relief in subjectve parameters like	At 1st,10th,20th,30th day
1)Kandu(itching)	At 1st,10th,20th,30th day
2)Raga(erythema)	At 1st,10th,20th,30th day
3)Size of utsanna mandal(elevated circular skin lesion)	At 1st,10th,20th,30th day
4)No.of utsanna zero mandal(elevated circular skin lesion)	At 1st,10th,20th,30th day
5)Pidika(eruption)	At 1st,10th,20th,30th day

Secondary Outcome Measures

Name	Time	Method
Relief in objectve parameters-1)TLC	2)DLC

Trial Locations

Locations (1)

Gurukul Campus UAU Haridwar; 🇮🇳 Hardwar, UTTARANCHAL, India

Gurukul Campus UAU Haridwar

🇮🇳Hardwar, UTTARANCHAL, India

Amandeep Kaur

Principal investigator

7017991277

kauramandeep0392@gmail.com